Kentucky BioProcessing LLC (KBP) has been awarded a patent for a veterinary vaccine produced with tobacco plants. KBP’s parvovirus vaccine, which has potential for both feline and canine applications, builds on the company’s already-patented Geneware technology, a plant-based gene expression systems that uses a specifically altered tobacco mosaic virus as a vehicle to carry a target protein. Once the altered virus is introduced into a host plant, the natural growth of the plant causes the protein to be reproduced in larger quantities.
-
Share This!
Owensboro
October 1, 2008
342 Views
You may also like
Popular Stories
EKPC plans $335.4M solar farms in Fayette, Marion counties
April 29, 2024
2024 SOAR Gala recognizes 14 individuals and organizations
April 29, 2024
Fading lights: Study unveils threats to firefly populations
April 29, 2024
The Lane Report
- Carol Dan Browning Appointed Chair of Pharmaceuticals & Medical Devices Litigation Group
- Newport agrees to $20M hotel project at World Peace Bell site
- 2024 SOAR Gala recognizes 14 individuals and organizations
- Drew Ulmer Named Member With Baldwin CPAS
- Fading lights: Study unveils threats to firefly populations
- Norton Healthcare, Norton Children’s expanding in Bowling Green
- EKPC plans $335.4M solar farms in Fayette, Marion counties
- Northern Kentucky University installs first female president
- Stites & Harbison makes 2024 Top 10 list in Patent Lawyer Magazine
- Buffalo Trace Distillery London
Add Comment